Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability.

ABSTRACT:

Background

Clinical trial transparency is important to participants, trialists, publishers, and regulators, and there have been recent major policy changes by the pharmaceutical industry regarding clinical study data sharing. However, it is unknown if these changes are enabling independent researchers to access participant-level data from prominent contemporary clinical trials sponsored by the pharmaceutical industry 2 years after publication of the primary results.

Main text

PubMed and ClinicalTrials.gov were searched to identify clinical trials of medicines sponsored by the pharmaceutical industry and first published between 1 July 2015 and 31 December 2015 in the top 10 general and internal medical journals by impact factor. For each clinical trial, the eligibility of ind

SUBMITTER: Hopkins AM 

PROVIDER: S-EPMC6161442 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature